Boothbay Fund Management »

Spruce Biosciences shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 42k 65.35
2025-12-31 $4.2M 48k 87.11

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Spruce Biosciences

Ikarian Capital
Millennium Management
Citadel Advisors
Wellington Management Company
ADAR1 Capital Management
Alyeska Investment Group
Boothbay Fund Management
Balyasny Asset Management
Carlyle
Quinn Opportunity Partners
Caligan Partners
Stonepine Capital Management
Vanguard Group
BlackRock
Geode Capital Management

View all funds holding Spruce Biosciences